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Abstract   
The role of the serum lipids (total cholesterol, high-density lipoprotein cholesterol /HDL-C/, 
low-density lipoprotein cholesterol /LDL-C/, triglycerides /TG/) in the pathophysiology of the 
mood disorders is not clear. The aim of this study was to determine lipid profile in patients 
with affective disorders. The study included medication free female subjects: 41 patients with 
bipolar disorder (22 in a manic and 19 in a depressive phase), 34 patients with major 
depression and 50 healthy controls. Serum lipids levels were determined using standard 
laboratory tests. All patients had significantly lower HDL-C values than control subjects. 
Increased TG levels were found in patients with bipolar disorder compared to healthy 
subjects. The changes in lipids profiles persisted when data were adjusted for age, smoking 
and menopause. The results revealed no differences in the cholestrol and LDL-C levels and 
body mass index, but significant differences in the ratios of cholesterol/HDL-C and LDL-
C/HDL-C values (atherogenic index) among groups. Our results suggest that low HDL-C 
levels and high atherogenic index might be a hallmark of affective disorders. Since low HDL-
C levels could be a risk factor for the development of coronary heart disease, further 
investigation of the lipids metabolism in affective disorders is warranted. 
Key words: Major depressive disorder; Bipolar disorder, mania; Cholesterol, High-density-
lipoprotein cholesterol, Low-density-lipoprotein cholesterol, Triglycerides. 
1. Introduction 
 
Various studies (Horsten et al., 1997; Maes et al., 1997; Ghaemi et al., 2000; Atmaca et al., 
2002; Cassidi and Carroll, 2002; Pae et al., 2004) suggested that pathophysiology of mood 
disorders might be related to the alterations in the lipid profile. Although in general 
population women with low levels of high-density lipoprotein cholesterol (HDL-C) (Horsten 
et al., 1997; Chen et al., 2001) and low cholesterol levels (Horsten et al., 1997) had more 
depressive symptoms than women with normal lipid levels, the association between total 
cholesterol, HDL-C, low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) levels 
and affective disorders is still not clear. Namely, clinical studies evaluating the relationship 
between cholesterol levels and affective disorders yielded inconsistent results. Decreased 
cholesterol levels were found in patients with mania (Ghaemi et al., 2000; Cassidi and Carroll, 
2002; Atmaca et al., 2002; Pae et al., 2004; Sagud et al., 2007), while lower (Maes et al., 
1997), or unaltered (Oxenkrug et al., 1983; Huang et al., 2003) serum cholesterol levels were 
found in female patients with major depression.  
A few data presented the entire lipid profile (i.e. cholesterol, HDL-C, LDL-C, TG) in 
affective disorders. It has been reported that patients with affective disorders had 
hypocholestrolemia with lower LDL-C and higher HDL-C and TG levels than healthy 
controls (Glueck et al., 1994), while first degree relatives of bipolar patients had lower HDL-
C levels than corresponding healthy controls (Sobczak et al., 2004). Since studies 
investigating lipid profile in affective disorders, particularly in bipolar disorder in a manic or a 
depressed phase, are scarce and inconsistent, the aim of the present study was to determine 
serum levels of total cholesterol, TG, HDL-C and LDL-C in medication-free female patients 
with major depression and bipolar disorder (in a manic and a depressive episode), and to 
compare these values with the values in healthy control women. 
2. Methods 
 
2.1. Subjects 
The study population comprised of 41 female, medication-free inpatients with bipolar I 
disorders (22 in manic and 19 in depressive episode), 34 female patients with major 
depression and 50 healthy female subjects. Patients were diagnosed using the structured 
clinical interview for DSM-IV disorders (APA, 1994). Manic patients scored at least 18 on 
the Young Mania Rating Scale (YMRS) (Young et al., 1978) and 7 or less on the 17-item 
Hamilton Depression Rating Scale (HAM-D17) (Hamilton, 1960). Patients with bipolar 
depression or major depressive disorder scored at least 18 on the HAMD-17, and 5 or less on 
the YMRS. Exclusion criteria were: a history of schizophrenia, dementia, schizoaffective 
disorder, alcohol abuse in previous month, serious medical disease (including cardiovascular 
disease), no change ± 5% of their body weight in the previous 3 months, elevated (>7.0 
mmol/L) cholesterol levels, use of cholesterol-lowering drugs, pregnancy, lactation and 
suicidal behavior (patients who scored 2 or more on item 3 on the HAMD-17). All patients 
were free of psychotropic medication for at least 2 weeks (washout period ranged between 14 
days to 5 years) prior to study entry, except for benzodiazepine equivalent for 2 mg of 
lorazepam daily. Control group consisted of medication free healthy women, recruited mostly 
from medical staff, with no personal history of any psychiatric disorder. Nine patients with 
mania, 7 patients with depressive phase of the bipolar disorder, 13 patients with major 
depression and 17 healthy controls were in menopause. 
 
 
 
Written informed consent was obtained from all participants, under procedures approved by 
Local Ethics Committee and in accordance with the Helsinki Declaration. 
 
2.2. Blood collection and biochemical measurements 
Blood samples were drawn in the morning after an overnight fasting for 12 hours. Serum 
cholesterol, HDL-C and TG levels were determined by the enzymatic color test for clinical 
analyzers, with the linearity within concentrations range of 0.64-18 mmol/l, 0.05-4.65 mmol/l 
and 0.11-11.40 mmol/l for serum cholesterol, HDL-C and TG, respectively. Serum LDL-C 
levels were determined by enzymatic clearance assay, with linearity up to 22.4 mmol/l.  
Body mass index (BMI) was calculated by dividing the weight (in kilograms) by squared 
height (in meters).  
 
2.3. Statistical procedures              
All results were expressed as mean ± S.D. Results were evaluated using one-way analysis of 
variance (ANOVA), followed by a Tukey’s HSD test for multiple comparisons. Analysis of 
covariance (ANCOVA) was used with age, smoking and menopause as covariates. The 
significance level was P<0.05. The statistical package used was SigmaStat 3.1 and SPSS 11.0. 
 
 
 
 
 
 
 
 
3. Results 
 
The demographic characteristics of patients and healthy controls are presented in Table 1. No 
significant difference in age (F3, 121 =2.011, P=0.11, ANOVA) and BMI (F3, 121=1.581, 
P=0.19) was observed between groups.  
 
Serum HDL-C levels were significantly (F3, 121=22.575, P=0.000) different in healthy controls 
and patients with major depressive or bipolar disorder (Fig. 1). Significantly lower serum 
HDL-C values were observed in patients with bipolar disorder in manic (P<0.001; Tukey’s 
HSD) or depressive (P<0.001, Tukey’s test) episodes, and with major depression (P<0.001, 
Tukey’s test), when compared to healthy controls. HDL-C levels were significantly different 
among groups when data were adjusted for age (F4=18.606, P<0.000), smoking (F4= 16.838, 
P<0.000) and menopause (F4 = 18.968, P<0.000) as covariates (ANCOVA). 
 
There was a significant (F3 =6.909, P<0.000) difference in serum TG levels among groups 
(Fig. 2). Patients with bipolar disorders in manic (P=0.007, Tukey’s HDS test) or depressive 
(P<0.001 Tukey’s HDS test) episode had significantly higher TG values than healthy 
controls. Serum TG values were significantly (P<0.048) higher in bipolar disorder in a 
depressed phase, than in patients with major depression. TG levels were significantly different 
among groups when data were adjusted for age (F4 = 5,195, P<0.001), smoking (F4= 5.787, 
P<0.000) and menopause (F4 = 5.139, P<0.001) as covariates (ANCOVA). 
 
Serum cholesterol and LDL-C concentrations did not differ significantly between healthy 
controls and patients with major depression or bipolar disorder (Table 2). Age (F4 =1.416, 
P=0.218; ANCOVA), smoking (F4 =0.397, P=0.811, ANCOVA) and menopause (F4 =0.486, 
P=0.746, ANCOVA) did not influence serum cholesterol levels among subjects. There was 
no significant effect of age (F4 =2.071, P=0.089, ANCOVA), smoking (F4 =1.437, P=0.226, 
ANCOVA) and menopause (F4 =1.442, P=0.224, ANCOVA) on serum LDL-C levels among 
subjects. 
 
Atherogenic index differed significantly among groups (Table 2). Patients with major 
depression and patients with both phases of bipolar disorder had significantly (P<0.000, 
Tukey’s HSD) higher cholesterol/HDL-C and LDL-C/HDL-C ratios than healthy controls. 
Patients with bipolar disorder in a depressive phase (Table 2) had significantly (P=0.045, 
Tukey’s HSD) higher cholesterol/HDL-C ratio than bipolar patients in a manic phase and 
patients with major depression (P<0.012, Tukey’s HSD). The LDL-C/HDL-C ratio was 
significantly (P=0.01, Tukey’s HSD) higher in patients with bipolar disorder in a depressive 
phase than in patients with major depression (Table 2). 
 
4. Discussion 
 
The results of the present study showed that patients with major depression and bipolar 
disorder (in a manic and a depressed episode) had lower HDL-C values and higher 
atherogenic index (cholesterol/HDL-C and LDL-C/HDL-C) than control subjects. In addition, 
we have shown the higher TG levels in patients with bipolar disorder, both in a manic and a 
depressed phase compared to patients with major depression or healthy controls. 
 
Our data agree with the reported association between low HDL-C levels and depression 
(Maes et al., 1997; Huang, 2005). Low HDL-C levels were proposed to be a characteristic 
feature of major depression per se, and not of the subgroups such as melancholia (Maes et al., 
1997, Huang, 2005), treatment resistant depression (Maes et al., 1997), or single or recurrent 
episodes (Huang, 2005). Our results suggest that lower HDL-C levels and higher atherogenic 
index, found in patients with major depression, patients with bipolar depression, and patients 
with mania, might represent a hallmark of affective disorders. These results also agree with 
the hypothesis that HDL-C might be a trait, rather than a state marker in bipolar disorders 
(Sobczak et al., 2004).  
 
Lower HDL-C values might be influenced by different factors such as sex, cholesterol-
lowering drugs, suicidal behavior, or altered serotonergic function. Sex differences in lipid 
levels, with lower HDL-C levels (Sudhop, 1999; Zhang et al., 2005) and higher LDL and TG 
levels (Sudhop, 1999) in healthy men than in healthy women were found. Since present study 
included only female subjects, lower HDL-C levels were not influenced by sex. Recent 
suicidal attempts were shown to decrease HDL-C levels in depressed men but not in 
depressed women (Maes et al., 1997). In our study patients with recent suicidal attempt were 
not included, and therefore lower HDL-C levels were not due to the history of suicidal 
behavior. Lower HDL-C levels might result from the altered serotonergic function (Buydens-
Branchey et al., 2000), as indicated by the positive correlations between HDL-C levels and 
serotonin metabolite, 5-hydroxyindoleacetic acid, in suicide attempters (Engstrom et al., 
1995), altered platelet serotonin in bipolar disorder (Sagud et al., 2007), and the inverse 
relationship between platelet serotonin and suicidal behavior in depressed patients (Muck-
Seler et al., 1996).  
 
The slight increase in TG values in patients with major depression are in line with higher TG 
levels found in female patients with major depression, compared to healthy control group 
(Huang, 2005). It has been suggested that plasma TG concentrations have an important role in 
the content and distribution of HDL subclasses (Yang et al., 2005). Mean TG values (>1.69 
mmol/L), observed in our patients with bipolar disorders, fit in the values related to higher 
concentrations of preß1-HDL (i.e. small-sized HDL particles) and lower concentration of 
HDL2b (i.e. larger-HDL particles) (Yang et al 2005). Although we have not determined the 
HDL subclasses, our findings of the increased TG and decreased HDL-C levels suggest a 
larger production of smaller-sized HDL particles, altered reverse cholesterol transport and 
abnormal HDL production in our patients.  
 
In contrast to previous reports of the altered cholesterol and LDL-C values in major 
depression (Maes et al., 1997), and bipolar disorders (Ghaemi et al., 2000; Atmaca et al., 
2002; Cassidi and Carroll, 2002; Pae et al., 2004; Sagud et al., 2007), we have found similar 
serum cholesterol and LDL-C levels in patients and control subjects. Possible explanation for 
the discrepancies among studies might be sought in a variety of factors, like sex, medication 
status (Maes et al., 1997), decreased appetite/weight loss (Boston et al., 1996), or suicide 
attempts (Marcinko et al., 2007). Since our study included medication-free female subjects 
who were not suicidal, and their BMI did not differ between groups, our results agree with the 
suggestion that cholesterol levels could not be biological marker for major depression 
(Oxenkrug et al., 1983). In addition, our results obtained in medication free patients suggest 
that both cholesterol and LDL-C levels are not related to diagnostic entities such as major 
depression or bipolar disorder. The differences in the lipid profile among studies might be 
related to the diverse medication status. Namely, it has been reported that treatment with 
antidepressants (Maes et al., 1997), and psychoactive drugs (Glueck et al., 1994), significantly 
decreased both serum cholesterol and HDL-C levels in patients with major depression, or 
affective disorders. Numerous psychoactive drugs were shown to influence lipid levels: 
valproate reduced cholesterol levels (Bowden and Singh, 2005), carbamazepine increased 
cholesterol, LDL-C and HDL-C levels (Weisler et al., 2005), while antipsychotic drugs 
increased cholesterol, TG and LDL-C levels (Saari et al., 2004). Therefore, the comparison of 
cholesterol levels in patients receiving pharmacological treatment and medication-free healthy 
controls (Glueck et al., 1994) is questionable.  
HDL-C has a role in the reverse cholesterol transport and complex cholesterol homeostasis, 
processes important in the protection of the cardiovascular system (Norata et al., 2006; 
Sampietro et al., 2006). The results of our study, showing low HDL-C and high TG levels, 
suggest that patients with mood disorders are at higher risk for the development of 
cardiovascular disorders (Lesperance et al., 1996; Polk and Naqui, 2005). Since we have also 
found that mean HDL-C values in our female patients with mania, bipolar and major 
depression were within the values associated with the greatest risk for development of 
coronary heart disease (Wilson et al., 1998; Franceschini, 2001), these results recommend that 
our patients should be further followed up.   
The limitations of the study were that the data on the physical activity, alcohol and dietary 
habits were not collected. In addition, we did not measure HDL-C subclasses (Yang et al 
2005).  
In conclusion, our data showed an inverse relationship between HDL-C and TG levels in 
patients with mood disorders, particularly in those with bipolar disorder (in a manic or a 
depressive phase). Due to the cross-sectional design, it is not possible to conclude whether 
low HDL-C levels and high atherogenic index contributed to a vulnerability to develop 
affective disorders, or low HDL-C levels occurred during the course of mood disorders. Since 
low HDL-C and increased atherogenic index are the risk factors for development of coronary 
heart disease, further investigations of lipid metabolism in affective disorders are warranted.  
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Legends to figures 
 
Fig 1. Serum HDL-C levels in healthy controls, patients with major depressive disorders and 
patients with bipolar disorders in manic or depressive episodes. Each column represents mean 
 SD. Number of subjects is given in brackets. 
*P<0.001 vs. healthy controls (ANOVA and Tukey’s test) 
 
 
Fig 2. Serum TG levels in healthy controls, patients with major depressive disorders and 
patients with bipolar disorders in manic or depressive episodes. Each column represents mean 
 SD. Number of subjects is given in brackets. 
*P =0.048 vs. major depression; **P=0.007 vs. healthy controls; 
*** P<0.001 vs. healthy controls (ANOVA and Tukey’s test) 
 
 
 
 
 
 
 
 
 
Table 1. Demographic characteristics of patients with bipolar disorder (in a manic and a 
depressed phase), patients with major depression, and healthy controls. Data are presented as 
means  SD. The number of subjects is given in breackets. 
      Bipolar  disorder 
 Manic 
episode 
(22) 
Depressive 
episode 
(19) 
Major 
depressive 
Disorder 
(34) 
Healthy 
Controls 
 
(50) 
Age (years) 48.5 ± 13.2 44.1 ± 12.9 50.1 ± 6.6 44.7± 12.8 
BMI (kg/m2) 24.7 ± 4.5 23.3 ± 2.4 24.3 ± 2.2 24.0 ± 4.5 
YMRS (scores) 26.1 ± 6.0    
HAMD (scores) 5.7 ± 1.6 27.3 ± 4.2 26.1 ± 2.2  
Disorder duration (years) 9.4 ± 9.6 12.5 ± 9.8 12.7 ± 10.4  
Current episode duration (days) 10.4 ± 11.3 4.2 ± 3.0 3.2 ± 1.5  
Number of prior manic episodes 5.2 ± 7.5 4.6 ± 5.8   
Number of prior depressive episodes 6.7 ± 9.2 7.9 ± 7.8 3.1 ± 2.9  
 
 
 
 
 
 
 
 
 
Table 2. Serum cholesterol, LDL-C levels and atherogenic index (cholesterol/HDL-C and LDL-C/HDL-C 
ratio) in healthy controls, patients with major depressive disorders, and patients with bipolar disorders in 
manic or depressive episodes. Results are expressed as means  SD. Number of subjects is given in 
brackets. 
 Atherogenic index 
 
 
Cholesterol 
(mmol/L) 
 
LDL-C 
(mmol/L) Cholesterol/HDL-C  LDL-C/HDL-C 
Healthy controls (50) 5.43  1.05 3.39  0.68 3.34  0.93 2.11  0.69 
Major depression (34) 5.17 0,90 3.43 0.77 4.55 0,96* 3.02 0.77* 
Bipolar disorder in: 
- manic episode (22) 
-depressive episode (19) 
 
5.39  1.27 
5.43  0.58 
 
3.68  0.94 
3.79 0.56 
 
4.62  1.29* 
5.49  1.24*,**,*** 
 
3.26  1.33* 
  3.80 0.67*,# 
ANOVA (df =  3, 121)     
F 0.503 1.899 22.764 22.250 
P 0.681 0.133 <0.001 <0.001 
*P<0.000 vs. corresponding ratio in healthy controls;  **P<0.045 vs. cholesterol/HDL-C ratio in 
bipolar disorder in manic episode ***P<0.012 vs. cholesterol/HDL-C ratio in major depression   # 
P<0.010 vs. LDL-C/HDL-C ratio in major depression  (ANOVA followed by Tukey’s test) 
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